Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivana Nemeckova

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Atherosclerosis|November 2, 2015
Soluble endoglin, hypercholesterolemia and endothelial dysfunctionJana Rathouska, Katerina Jezkova, Ivana Nemeckova, et al.
Histology and Histopathology|September 12, 2014
Endoglin is not expressed with cell adhesion molecules in aorta during atherogenesis in apoE-deficient miceJana Rathouska, Katerina Jezkova, Ivana Nemeckova, et al.
Heart and Vessels|March 18, 2014
Cell adhesion molecules and eNOS expression in aorta of normocholesterolemic mice with different predispositions to atherosclerosisJana Rathouska, Ivana Nemeckova, Lenka Zemankova, et al.
BMC Cardiovascular Disorders|April 16, 2024
Transgenic human C-reactive protein affects oxidative stress but not inflammation biomarkers in the aorta of spontaneously hypertensive ratsIvana Nemeckova, Samira Eissazadeh, Jana Urbankova Rathouska, et al.
Scientific Reports|October 31, 2025
Cost-effective method for semi-quantitative analysis of soluble endoglin in biological samples after anti-endoglin monoclonal antibody treatmentSamira Eissazadeh, Jana Urbankova Rathouska, Ivana Nemeckova, et al.
Atherosclerosis|March 14, 2026
Soluble endoglin as a biomarker of cardiovascular and metabolic disorders related to endothelial dysfunction: a systematic review and meta-analysisJana Urbankova Rathouska, Maryam Emadzadeh, Ivana Nemeckova, et al.
Plos One|July 9, 2016
An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic SteatohepatitisVeronica Marin, Natalia Rosso, Matteo Dal Ben, et al.
Atherosclerosis|February 21, 2018
Soluble endoglin and hypercholesterolemia aggravate endothelial and vessel wall dysfunction in mouse aortaBarbora Vitverova, Katerina Blazickova, Iveta Najmanova, et al.
Food & Function|September 24, 2013
Spirulina platensis and phycocyanobilin activate atheroprotective heme oxygenase-1: a possible implication for atherogenesisZbynek Strasky, Lenka Zemankova, Ivana Nemeckova, et al.
Plos One|March 14, 2015
High soluble endoglin levels do not induce endothelial dysfunction in mouse aortaIvana Nemeckova, Agnieszka Serwadczak, Barbara Oujo, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Atherosclerosis|November 2, 2015
Soluble endoglin, hypercholesterolemia and endothelial dysfunctionJana Rathouska, Katerina Jezkova, Ivana Nemeckova, et al.
Histology and Histopathology|September 12, 2014
Endoglin is not expressed with cell adhesion molecules in aorta during atherogenesis in apoE-deficient miceJana Rathouska, Katerina Jezkova, Ivana Nemeckova, et al.
Heart and Vessels|March 18, 2014
Cell adhesion molecules and eNOS expression in aorta of normocholesterolemic mice with different predispositions to atherosclerosisJana Rathouska, Ivana Nemeckova, Lenka Zemankova, et al.
BMC Cardiovascular Disorders|April 16, 2024
Transgenic human C-reactive protein affects oxidative stress but not inflammation biomarkers in the aorta of spontaneously hypertensive ratsIvana Nemeckova, Samira Eissazadeh, Jana Urbankova Rathouska, et al.
Scientific Reports|October 31, 2025
Cost-effective method for semi-quantitative analysis of soluble endoglin in biological samples after anti-endoglin monoclonal antibody treatmentSamira Eissazadeh, Jana Urbankova Rathouska, Ivana Nemeckova, et al.
Atherosclerosis|March 14, 2026
Soluble endoglin as a biomarker of cardiovascular and metabolic disorders related to endothelial dysfunction: a systematic review and meta-analysisJana Urbankova Rathouska, Maryam Emadzadeh, Ivana Nemeckova, et al.
Plos One|July 9, 2016
An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic SteatohepatitisVeronica Marin, Natalia Rosso, Matteo Dal Ben, et al.
Atherosclerosis|February 21, 2018
Soluble endoglin and hypercholesterolemia aggravate endothelial and vessel wall dysfunction in mouse aortaBarbora Vitverova, Katerina Blazickova, Iveta Najmanova, et al.
Food & Function|September 24, 2013
Spirulina platensis and phycocyanobilin activate atheroprotective heme oxygenase-1: a possible implication for atherogenesisZbynek Strasky, Lenka Zemankova, Ivana Nemeckova, et al.
Plos One|March 14, 2015
High soluble endoglin levels do not induce endothelial dysfunction in mouse aortaIvana Nemeckova, Agnieszka Serwadczak, Barbara Oujo, et al.
Pageof 2